Aceto Corporation  

(Public, NASDAQ:ACET)   Watch this stock  
Find more results for ACET
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 16.52 - 24.30
Open     -
Vol / Avg. 0.00/118,667.00
Mkt cap 689.17M
P/E 27.15
Div/yield 0.06/1.01
EPS 0.87
Shares 29.12M
Beta 1.72
Inst. own 83%
Jun 3, 2015
Aceto Corp at Jefferies Global Healthcare Conference - 1:30PM EDT - Add to calendar
May 8, 2015
Q3 2015 Aceto Corp Earnings Call - Webcast
May 7, 2015
Q3 2015 Aceto Corp Earnings Release
Apr 14, 2015
ACETO at the Needham 14th Annual Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 5.77% 5.68%
Operating margin 10.58% 8.68%
EBITD margin - 10.26%
Return on average assets 7.02% 7.33%
Return on average equity 14.09% 13.54%
Employees 270 -
CDP Score - -


4 Tri Harbor Ct
United States - Map
+1-516-6276000 (Phone)
+1-516-6276093 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Aceto Corporation (Aceto) is a pharmaceutical and specialty chemicals company. The Company markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The Company distributes more than 1,100 chemical compounds, which are used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Company operates in three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment makes nutritional products and drugs for human consumption. The Pharmaceutical Ingredients segment is engaged in generic drugs manufacturing for pharmaceutical companies. The Performance Chemicals segment makes a range of chemical products for multiple uses in a variety of industries.

Officers and directors

Albert L. Eilender Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Salvatore J. Guccione President, Chief Executive Officer, Chief Operating Officer, Director
Age: 51
Bio & Compensation  - Reuters
Douglas A. Roth Chief Financial Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Satish Srinivasan President and Chief Operating Officer of Rising Pharmaceuticals
Age: 45
Bio & Compensation  - Reuters
Steven Rogers Senior Vice President, General Counsel, Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Charles J. Alaimo Senior Vice President - Human Resources
Age: 48
Bio & Compensation  - Reuters
Raymond Bartone Senior Vice President - Nutritionals
Age: 52
Bio & Compensation  - Reuters
Frank V. DeBenedittis Senior Vice President - Corporate Business Development
Age: 60
Bio & Compensation  - Reuters
Terry Kippley Senior Vice President - Agricultural Protection Products
Age: 50
Bio & Compensation  - Reuters
Carlos Restrepo Senior Vice President - Performance Chemicals
Age: 52
Bio & Compensation  - Reuters